Literature DB >> 25894549

Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.

K A Ponto1,2, H Elbaz1,3,4, T Peto3, D Laubert-Reh1,5, H Binder6, P S Wild2,5,7, K Lackner8, N Pfeiffer1, A Mirshahi1,9.   

Abstract

OBJECTIVE: To determine the age- and sex-specific prevalence and determinants of retinal vein occlusions (RVOs) in a large population-based German cohort.
METHODS: The investigation included 15,010 participants (aged 35-74 years) from the Gutenberg Health Study. We determined the prevalence of RVO (central retinal vein occlusion [CRVO] and branch retinal vein occlusion [BRVO]) for the local population by assessing fundus photographs of 12 954 (86.3%; 49.8% women and 50.2% men) participants. Further, we analyzed the associations of RVO with cardiovascular, anthropometric, and ophthalmic parameters.
RESULTS: The weighted prevalences of RVO, CRVO, and BRVO were 0.40%, 0.08%, and 0.32%, respectively. Men were 1.7 times more frequently affected by RVO than were women. Prevalence of RVO was 0.2% in participants aged 35-44 and 45-54 years, respectively, 0.48% in those aged 55-64 years, and 0.92% in those aged 65-74 years. Of persons with RVO, 91.5% had one or more cardiovascular risk factor or disease vs. 75.9% of persons without RVO. BRVO was associated with arterial hypertension (odds ratio 2.69, 95% confidence interval 1.27-5.70) and atrial fibrillation (3.37, 1.24-9.12) and CRVO with higher age (7.02, 1.63-30.19) and a family history of stroke (4.64, 1.18-18.25). Median visual acuity (base 10 logarithm of minimum angle of resolution) was 0.2 in persons with RVO vs. 0.05 in those without.
CONCLUSION: The prevalence of RVO in this German population was 0.4%, and men were 1.7 times more frequently affected than women. CRVO was associated with higher age and a family history of stroke, and BRVO was associated with arterial hypertension and atrial fibrillation.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  population; prevalence; retinal disease; retinal vein occlusion; risk factors

Mesh:

Year:  2015        PMID: 25894549     DOI: 10.1111/jth.12982

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

1.  Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.

Authors:  Julie Blanc; Clémence Deschasse; Laurent Kodjikian; Corinne Dot; Alain-Marie Bron; Catherine Creuzot-Garcher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-31       Impact factor: 3.117

2.  Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study.

Authors:  Melissa Mei Hsia Chan; Akshay S Thomas; Stephen P Yoon; Diana Leitner; Sharon Fekrat
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-07-01       Impact factor: 1.300

3.  Posterior segment eye lesions: prevalence and associations with ocular and systemic parameters: results from the Gutenberg Health Study.

Authors:  Hisham Elbaz; Andreas Schulz; Katharina A Ponto; Stefan Nickels; Norbert Pfeiffer; Alireza Mirshahi; Tunde Peto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-18       Impact factor: 3.117

Review 4.  [Retinal vein occlusion : Epidemiology, classification and clinical findings].

Authors:  N Feltgen; A Pielen
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

5.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

6.  [Incidence of retinal vein occlusion during the football World Cup in 2014 : A database analysis].

Authors:  F Lob; K Kortüm; M Müller; J Märtz; S Leicht; K Prause; S Priglinger; T Kreutzer
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

7.  Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Michael S Ip; Barbara A Blodi; Neal L Oden; Carl C Awh; Derek Y Kunimoto; Dennis M Marcus; John J Wroblewski; Jacqueline King
Journal:  JAMA       Date:  2017-05-23       Impact factor: 56.272

8.  Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.

Authors:  Yangjiani Li; Nathan E Hall; Suzann Pershing; Leslie Hyman; Julia A Haller; Aaron Y Lee; Cecilia S Lee; Michael Chiang; Flora Lum; Joan W Miller; Alice Lorch; Tobias Elze
Journal:  Ophthalmol Retina       Date:  2021-05-12

9.  Relationship between Retinal Vascular Occlusions and Cognitive Dementia in a Large Cross-Sectional Cohort.

Authors:  Alison X Chan; Christine Y Bakhoum; Katherine J Bangen; Mathieu F Bakhoum
Journal:  Am J Ophthalmol       Date:  2021-01-30       Impact factor: 5.488

10.  Spectral Domain OCT Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2: SCORE 2 Report 15.

Authors:  Tyler Etheridge; Barbara Blodi; Neal Oden; Paul Van Veldhuisen; Ingrid U Scott; Michael S Ip; Mihai Mititelu; Amitha Domalpally
Journal:  Ophthalmol Retina       Date:  2020-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.